Blog

Blog

Drug Target Encyclopedia Series (28) —FOLR1

Linkedin

Release Time：

2026-01-13 13:58

 

  FOLR1 (Folate Receptor Alpha, FRα) is a GPI-anchored membrane protein that mediates high-affinity folate uptake.Under physiological conditions, FOLR1 expression is low and polarized in normal epithelial tissues, but it is markedly upregulated in multiple solid tumors, making it a highly differentiated and clinically validated oncology target.

What is FOLR1? 

  • High-affinity folate-binding receptor
  • Anchored on the cell surface via GPI linkage
  • Enables folate internalization through receptor-mediated endocytosis
  • Expression pattern: tumor-enriched, normal tissue–restricted

This sharp tumor–normal contrast is the core reason FOLR1 has become a premium ADC and targeted delivery receptor.

Disease & Drug Value

FOLR1 is highly expressed in:

  • Ovarian cancer (high-grade serous, strongest clinical validation)
  • Endometrial cancer
  • Non–small cell lung cancer (adenocarcinoma)
  • Triple-negative breast cancer (subset)
  • Certain renal and gastric cancers

High FOLR1 expression correlates with:

  • Aggressive tumor biology
  • Poor prognosis
  • Strong suitability for targeted payload delivery

👉 Clinically, FOLR1 is one of the most successful solid tumor surface antigens beyond HER2.

Emerging Therapeutic Strategies 

🧪 Antibody–Drug Conjugates (ADCs)
The dominant modality for FOLR1:

  • Efficient receptor internalization
  • High tumor selectivity
  • Proven clinical responses in ovarian cancer

🧪 Bispecific antibodies

  • FOLR1 × CD3 approaches to redirect T cells
  • Requires tight control of on-target toxicity

🧪 Targeted imaging & radioligands

  • Companion diagnostics
  • Patient stratification for ADC eligibility

🧪 mRNA-based research tools

  • Rapid validation of FOLR1 expression constructs
  • ADC internalization and trafficking studies
  • CAR and bispecific design screening
  • Safer, transient expression for early discovery

Key Challenges

  • Managing on-target off-tumor toxicity
  • Tumor heterogeneity of FOLR1 expression
  • ADC payload optimization (potency vs safety)
  • Patient selection and biomarker cutoffs

Industry Takeaway

FOLR1 represents a gold-standard membrane target for solid tumors:

✔ Clear expression differential

✔ Strong internalization biology

✔ ADC-first commercial validation

✔ Expanding into bispecifics & imaging

As the ADC field matures, FOLR1 continues to define how “good targets” should look—biologically, clinically, and commercially.

Need FOLR1 tools for your research?

 

Fill out the form below, or visit the link: to browse the complete list of available in-stock products.  

 

Prev

Drug Target Encyclopedia Series (29) —CD142

Drug Target Encyclopedia Series (27) —KLRK1

Next